{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:33:13Z","timestamp":1787167993324,"version":"build-2736575974"},"reference-count":42,"publisher":"Informa UK Limited","issue":"5","license":[{"start":{"date-parts":[[2022,3,8]],"date-time":"2022-03-08T00:00:00Z","timestamp":1646697600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline Biologicals SA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline Biologicals SA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Human Vaccines & Immunotherapeutics"],"published-print":{"date-parts":[[2022,11,30]]},"DOI":"10.1080\/21645515.2022.2045152","type":"journal-article","created":{"date-parts":[[2022,3,8]],"date-time":"2022-03-08T11:27:54Z","timestamp":1646738874000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":9,"title":["Cost effectiveness and budget impact of universal varicella vaccination in Russia"],"prefix":"10.1080","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1046-9702","authenticated-orcid":false,"given":"Alen","family":"Marijam","sequence":"first","affiliation":[{"name":"GSK, Wavre, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8417-1963","authenticated-orcid":false,"given":"Ekaterina","family":"Safonova","sequence":"additional","affiliation":[{"name":"GSK, Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9189-4729","authenticated-orcid":false,"given":"Mikhail","family":"Scherbakov","sequence":"additional","affiliation":[{"name":"GSK, Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5026-3525","authenticated-orcid":false,"given":"Evgeniy","family":"Shpeer","sequence":"additional","affiliation":[{"name":"GSK, Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0382-0333","authenticated-orcid":false,"given":"Desir\u00e9e","family":"Van Oorschot","sequence":"additional","affiliation":[{"name":"GSK, Wavre, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0442-783X","authenticated-orcid":false,"given":"Alla","family":"Rudakova","sequence":"additional","affiliation":[{"name":"Pediatric Research and Clinical Center for Infectious Diseases, Saint Petersburg, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8085-4513","authenticated-orcid":false,"given":"Vladimir","family":"Tatochenko","sequence":"additional","affiliation":[{"name":"National Medical Scientific Centre of Children Health, Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6446-2744","authenticated-orcid":false,"given":"Nikolay","family":"Briko","sequence":"additional","affiliation":[{"name":"Sechenov First Moscow State Medical University of The Ministry of Health of the Russian Federation, Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2022,3,8]]},"reference":[{"key":"e_1_3_7_2_1","unstructured":"Centers for Disease Control and Prevention. Varicella. in: the Pink Book: Epidemiology and prevention of vaccine-preventable diseases. Washington D.C: National Center for Immunization and Respiratory Diseases; 2020 [accessed 2021 May 2]. https:\/\/www.cdc.gov\/vaccines\/pubs\/pinkbook\/varicella.html."},{"key":"e_1_3_7_3_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-017-2445-2"},{"key":"e_1_3_7_4_1","doi-asserted-by":"publisher","DOI":"10.2174\/157339609791317315"},{"key":"e_1_3_7_5_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2016.1181243"},{"key":"e_1_3_7_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2014.07.068"},{"key":"e_1_3_7_7_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.287.5.606"},{"key":"e_1_3_7_8_1","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES2013.18.32.20552"},{"key":"e_1_3_7_9_1","doi-asserted-by":"publisher","DOI":"10.2471\/BLT.13.132142"},{"key":"e_1_3_7_10_1","doi-asserted-by":"publisher","DOI":"10.1086\/522155"},{"key":"e_1_3_7_11_1","doi-asserted-by":"publisher","DOI":"10.1136\/adc.2007.126243"},{"key":"e_1_3_7_12_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2018.1546525"},{"key":"e_1_3_7_13_1","unstructured":"World Health Organization. WHO vaccine-preventable diseases: monitoring system. 2020 global summary. Geneva: World Health Organization; 2020 [accessed 2021 May 5]. http:\/\/apps.who.int\/immunization_monitoring\/globalsummary\/schedules."},{"key":"e_1_3_7_14_1","unstructured":"Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing (Rospotrebnadzor). On the state of sanitary and epidemiological welfare of the population in the Russian Federation in 2017. 2018 [accessed 2021 June 3]. https:\/\/www.rospotrebnadzor.ru\/documents\/details.php?ELEMENT_ID=10145."},{"key":"e_1_3_7_15_1","doi-asserted-by":"publisher","DOI":"10.31631\/2073-3046-2019-18-6-67-74"},{"key":"e_1_3_7_16_1","unstructured":"Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing (Rospotrebnadzor). \u0413\u043e\u0441\u0443\u0434\u0430\u0440\u0441\u0442\u0432\u0435\u043d\u043d\u044b\u0439 \u0434\u043e\u043a\u043b\u0430\u0434 \u041e \u0441\u043e\u0441\u0442\u043e\u044f\u043d\u0438\u0438 \u0441\u0430\u043d\u0438\u0442\u0430\u0440\u043d\u043e-\u044d\u043f\u0438\u0434\u0435\u043c\u0438\u043e\u043b\u043e\u0433\u0438\u0447\u0435\u0441\u043a\u043e\u0433\u043e \u0431\u043b\u0430\u0433\u043e\u043f\u043e\u043b\u0443\u0447\u0438\u044f \u043d\u0430\u0441\u0435\u043b\u0435\u043d\u0438\u044f \u0432 \u0440\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u043e\u0439 \u0444\u0435\u0434\u0435\u0440\u0430\u0446\u0438\u0438 \u0432 2019 \u0433\u043e\u0434\u0443; 2020 [accessed 2021 July 15]. https:\/\/www.rospotrebnadzor.ru\/documents\/details.php?ELEMENT_ID=14933."},{"key":"e_1_3_7_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-8579(07)71277-3"},{"key":"e_1_3_7_18_1","doi-asserted-by":"publisher","DOI":"10.22625\/2072-6732-2021-13-1-66-70"},{"key":"e_1_3_7_19_1","doi-asserted-by":"publisher","DOI":"10.15690\/pf.v9i5.450"},{"key":"e_1_3_7_20_1","doi-asserted-by":"publisher","DOI":"10.1136\/adc.88.10.862"},{"key":"e_1_3_7_21_1","unstructured":"Government of the Russian Federation. Decree of the Government of the Russian Federation of December 8 2017 No. 1492 \u201con the program of state guarantees of free provision of medical care to citizens for 2018 and for the planning period of 2019 and 2020\u201d. Moscow: Ministry of Health of the Russian Federation; 2017 [accessed 2021 May 9]. http:\/\/www.garant.ru\/products\/ipo\/prime\/doc\/71729300\/."},{"key":"e_1_3_7_22_1","unstructured":"State Register of Medicine. State register of maximum selling prices. Russian Federation; 2009 [accessed 2021 Apr 13]. http:\/\/grls.rosminzdrav.ru\/PriceLims.aspx?Torg=%d0%92%d0%b0%d1%80%d0%b8%d0%bb%d1%80%d0%b8%d0%ba%d1%81&Mnn=&RegNum=&Mnf=&Barcode=&Order=&PageSize=8&orderby=pklimprice&orderType=desc&pagenum=1."},{"key":"e_1_3_7_23_1","unstructured":"Emiss. Number of births (without stillbirths) per year. Russia: State Statistics [accessed 2021 May 6]. http:\/\/apps.who.int\/immunization_monitoring\/globalsummary\/schedules."},{"key":"e_1_3_7_24_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2016-1485"},{"key":"e_1_3_7_25_1","unstructured":"RosInfoStat. Mortality statistics according to Rosstat: RosInfoStat; 2021 [accessed 2021 Augt 13]. https:\/\/rosinfostat.ru\/smertnost\/#i-4."},{"key":"e_1_3_7_26_1","unstructured":"Federal State Statistics Service (ROSSTAT). Fertility according to rosstat data: RosInfoStat; 2021 [accessed 2021 July 14]. https:\/\/rosinfostat.ru\/rozhdaemost\/."},{"key":"e_1_3_7_27_1","unstructured":"GlaxoSmithKline Biologicals SA. \u0418\u043d\u0441\u0442\u0440\u0443\u043a\u0446\u0438\u044f \u043f\u043e \u043c\u0435\u0434\u0438\u0446\u0438\u043d\u0441\u043a\u043e\u043c\u0443 \u043f\u0440\u0438\u043c\u0435\u043d\u0435\u043d\u0438\u044e \u043b\u0435\u043a\u0430\u0440\u0441\u0442\u0432\u0435\u043d\u043d\u043e\u0433\u043e \u043f\u0440\u0435\u043f\u0430\u0440\u0430\u0442\u0430 \u0432\u0430\u0440\u0438\u043b\u0440\u0438\u043a\u0441\u00ae\/varilrix\u00ae: GlaxoSmithKline Biologicals SA; 2020 [accessed 2021 July 16]. https:\/\/gskpro.com\/content\/dam\/global\/hcpportal\/ru_RU\/varilrix\/pdf\/varilrix_pil_gds_v012_2017_05_11_aw_2017_06_19.pdf."},{"key":"e_1_3_7_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(18)30716-3"},{"key":"e_1_3_7_29_1","unstructured":"Federal Statistics Service. Key figure- Russia. Russian Federation; 2019 [accessed 2021 Mar 6]. https:\/\/www.gks.ru\/free_doc\/new_site\/m-sotrudn\/eng_site\/Key_Figures.pdf."},{"key":"e_1_3_7_30_1","unstructured":"Federal Tax Service of Russia. \u041d\u0430\u043b\u043e\u0433 \u043d\u0430 \u0434\u043e\u0445\u043e\u0434\u044b \u0444\u0438\u0437\u0438\u0447\u0435\u0441\u043a\u0438\u0445 \u043b\u0438\u0446 (\u041d\u0414\u0424\u041b); 2021 [accessed 2021 July 15]. https:\/\/www.nalog.gov.ru\/rn77\/taxation\/taxes\/ndfl\/."},{"key":"e_1_3_7_31_1","first-page":"49","article-title":"Economic assessment of vaccine prevention of children pox on the example of Moscow","volume":"3","author":"Shakhanina IL","year":"2009","unstructured":"Shakhanina IL, Gorelov AV, Lytkina IN, Tolkushin AG. Economic assessment of vaccine prevention of children pox on the example of Moscow. Epidemiology Infect Dis. 2009;3:49\u201356.","journal-title":"Epidemiology Infect Dis"},{"key":"e_1_3_7_32_1","unstructured":"Teplova TE Teplova EG \u041e\u0440\u0433\u0430\u043d\u0438\u0437\u0430\u0446\u0438\u044f\u0438 \u0441\u043e\u0432\u0435\u0440\u0448\u0435\u043d\u0441\u0442\u0432\u043e\u0432\u0430\u043d\u0438\u0435 \u043c\u0435\u0434\u0438\u0446\u0438\u043d\u0441\u043a\u043e\u0433\u043e\u043e\u0431\u0435\u0441\u043f\u0435\u0447\u0435\u043d\u0438\u044f\u0438\u0433\u043e\u0441\u0443\u0434\u0430\u0440\u0441\u0442\u0432\u0435\u043d\u043d\u043e\u0433\u043e\u0441\u0430\u043d\u0438\u0442\u0430\u0440\u043d\u043e\u044d\u043f\u0438\u0434\u0435\u043c\u0438\u043e\u043b\u043e\u0433\u0438\u0447\u0435\u0441\u043a\u043e\u0433\u043e \u043d\u0430\u0434\u0437\u043e\u0440\u0430. \u043f\u0440\u0435\u0434\u0443\u043f\u0440\u0435\u0436\u0434\u0435\u043d\u0438\u0435 \u0438 \u043b\u0438\u043a\u0432\u0438\u0434\u0430\u0446\u0438\u044f \u043f\u043e\u0441\u043b\u0435\u0434\u0441\u0442\u0432\u0438\u0439 \u0447\u0440\u0435\u0437\u0432\u044b\u0447\u0430\u0439\u043d\u044b\u0445 \u0441\u0438\u0442\u0443\u0430\u0446\u0438\u0439. 2012: medicine of extreme situations. [accessed 2021 July 27]. https:\/\/cyberleninka.ru\/article\/n\/ekonomicheskaya-effektivnost-vaktsinoprofilaktiki-vetryanoy-ospy-v-usloviyah-priblizhennyh-k-obscherossiyskim\/viewer."},{"key":"e_1_3_7_33_1","unstructured":"International Society for Pharmacoeconomics and Outcomes Research. Pharmacoeconomic guidelines around the world - Russian Federation 2018. 2018: ISPOR Russia HTA regional chapter. [accessed 2021 May 4]. https:\/\/tools.ispor.org\/PEguidelines\/countrydet.asp?c=18&t=4."},{"key":"e_1_3_7_34_1","doi-asserted-by":"publisher","DOI":"10.17749\/2070-4909\/farmakoekonomika.2020.071"},{"key":"e_1_3_7_35_1","unstructured":"Yagudina RI Sorokovikov IV. Methodology for conducting cost-benefit analysis in pharmacoeconomic research. 2012: \u041c\u0435\u0442\u043e\u0434\u043e\u043b\u043e\u0433\u0438\u044f \u0444\u0430\u0440\u043c\u0430\u043a\u043e\u044d\u043a\u043e\u043d\u043e\u043c\u0438\u0447\u0435\u0441\u043a\u043e\u0433\u043e \u0430\u043d\u0430\u043b\u0438\u0437\u0430. [accessed 2021 July 27]. https:\/\/cyberleninka.ru\/article\/n\/metodologiya-provedeniya-analiza-zatraty-poleznost-pri-provedenii-farmakoekonomicheskih-issledovaniy."},{"key":"e_1_3_7_36_1","first-page":"34","article-title":"Experience of vaccine prevention for varicella in Yekaterinburg","volume":"7","author":"Ksenofontova O","year":"2010","unstructured":"Ksenofontova O, Rozhkova L, Savvinova T, Kharitonov A. Experience of vaccine prevention for varicella in Yekaterinburg. Pediatr Pharmacol (New York). 2010;7:34\u201336.","journal-title":"Pediatr Pharmacol (New York)"},{"key":"e_1_3_7_37_1","first-page":"30","article-title":"Post-Exposure immunological prevention against varicella","volume":"7","author":"Tatochenko V","year":"2010","unstructured":"Tatochenko V, Ksenofontova O, Rozhkova L, Savvinova T, Kharitonov A. Post-Exposure immunological prevention against varicella. Pediatr Pharmacol (New York). 2010;7:30\u201333.","journal-title":"Pediatr Pharmacol (New York)"},{"key":"e_1_3_7_38_1","first-page":"63","article-title":"\u0412\u0415\u0422\u0420\u042f\u041d\u0410\u042f \u041e\u0421\u041f\u0410: \u0420\u0418\u0421\u041a-\u041e\u0420\u0418\u0415\u041d\u0422\u0418\u0420\u041e\u0412\u0410\u041d\u041d\u0410\u042f \u041c\u041e\u0414\u0415\u041b\u042c \u0423\u041f\u0420\u0410\u0412\u041b\u0415\u041d\u0418\u042f \u042d\u041f\u0418\u0414\u0415\u041c\u0418\u0427\u0415\u0421\u041a\u0418\u041c \u041f\u0420\u041e\u0426\u0415\u0421\u0421\u041e\u041c '\u2018Flowpox: A risk-based epidemic control model\u2019\u2019","volume":"39","author":"Smirnova SS","year":"2020","unstructured":"Smirnova SS, Yuzhanina TS, Stepanova EA, Rupysheva TA. \u0412\u0415\u0422\u0420\u042f\u041d\u0410\u042f \u041e\u0421\u041f\u0410: \u0420\u0418\u0421\u041a-\u041e\u0420\u0418\u0415\u041d\u0422\u0418\u0420\u041e\u0412\u0410\u041d\u041d\u0410\u042f \u041c\u041e\u0414\u0415\u041b\u042c \u0423\u041f\u0420\u0410\u0412\u041b\u0415\u041d\u0418\u042f \u042d\u041f\u0418\u0414\u0415\u041c\u0418\u0427\u0415\u0421\u041a\u0418\u041c \u041f\u0420\u041e\u0426\u0415\u0421\u0421\u041e\u041c '\u2018Flowpox: A risk-based epidemic control model\u2019\u2019. Far East J Infect Pathol. 2020;39:63\u201368.","journal-title":"Far East J Infect Pathol"},{"key":"e_1_3_7_39_1","doi-asserted-by":"publisher","DOI":"10.31631\/2073-3046-2020-19-4-63-75"},{"key":"e_1_3_7_40_1","unstructured":"Experts Nuo I Resolutions of the expert council on vaccine prevention. Moscow: Ministry of Health of the Russian Federation. [accessed 2021 July 24]. https:\/\/www.pediatr-russia.ru\/information\/vaktsinatsiya\/natsionalnyy-nezavisimyy-ekspertnyy-sovet-po-immunoprofilaktike\/natsionalnyy-soyuz-ekspertov-v-sfere-immunoprofilaktiki-.php."},{"key":"e_1_3_7_41_1","first-page":"491","article-title":"Resolution of the expert forum of Russian Federation '\u2018chickenpox: serious infection in Russian Federation, which can be prevented due to vaccination","volume":"18","author":"Vishneva EA","year":"2019","unstructured":"Vishneva EA, Kostinov MP, Mazankova LN, Malinnikova EY, Namazova-Baranova LS, Plakida AV, Privalova TE, Rtishchev AY, Tatochenko VK, Fedoseenko MV, et al. Resolution of the expert forum of Russian Federation '\u2018chickenpox: serious infection in Russian Federation, which can be prevented due to vaccination. Curr Pediatr. 2019;18:491\u201394.","journal-title":"Curr Pediatr"},{"key":"e_1_3_7_42_1","volume-title":"VSV: persistence in the population. Human herpesviruses: biology, therapy, and immunoprophylaxis","author":"Seward JF","year":"2007","unstructured":"Seward JF, Jumaan AO. VSV: persistence in the population. Human herpesviruses: biology, therapy, and immunoprophylaxis. Cambridge: Cambridge University Press; 2007."},{"key":"e_1_3_7_43_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2015.16"}],"container-title":["Human Vaccines & Immunotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/21645515.2022.2045152","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,5]],"date-time":"2024-02-05T16:13:54Z","timestamp":1707149634000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/21645515.2022.2045152"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,8]]},"references-count":42,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,11,30]]}},"alternative-id":["10.1080\/21645515.2022.2045152"],"URL":"https:\/\/doi.org\/10.1080\/21645515.2022.2045152","relation":{},"ISSN":["2164-5515","2164-554X"],"issn-type":[{"value":"2164-5515","type":"print"},{"value":"2164-554X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,8]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-09-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-02-18","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-03-08","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2045152"}}